Want to see SE:ZZ.B full AI Analyst Report?
Top Page
Zinzino AB
(ZZ.B)
Select Model
Select Model
Rating:82Outperform
Price Target:
kr148.00
▲(14.55% Upside)
Action:Reiterated
Date:05/23/26
The score is driven primarily by strong financial quality (low leverage, solid profitability, and excellent recent cash flow). Valuation is supportive with a moderate P/E and a ~2.7% dividend yield. Technicals are constructive but tempered by near-overbought signals and price still slightly below the 200-day average.
Positive Factors
Very low leverage
An extremely low debt-to-equity ratio materially reduces refinancing and downturn risk and preserves financial optionality. Over the next 2–6 months this balance-sheet conservatism supports investment in growth, shields cash flow from interest shocks, and underpins stable operations.
Negative Factors
Gross margin volatility
Volatile gross margins threaten durable profitability and cash flow if input costs, pricing pressure, or product mix shift unfavorably. Persistent margin swings would impair the company’s ability to fund growth and could erode the high cash conversion and ROE that currently support financial strength.
Read all positive and negative factors
Positive Factors
Negative Factors
Very low leverage
An extremely low debt-to-equity ratio materially reduces refinancing and downturn risk and preserves financial optionality. Over the next 2–6 months this balance-sheet conservatism supports investment in growth, shields cash flow from interest shocks, and underpins stable operations.
Read all positive factors
Zinzino AB (ZZ.B) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr5.15B
Dividend Yield4.57%
Average Volume (3M)111.67K
Price to Earnings (P/E)12.9
Beta (1Y)0.71
Revenue Growth42.70%
EPS Growth86.19%
CountrySE
Employees369
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)10.23
Shares Outstanding34,052,605
10 Day Avg. Volume55,948
30 Day Avg. Volume111,671
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)8.03
Price to Sales (P/S)1.79
P/FCF Ratio10.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)10.7
Revenue Forecast (FY)kr3.91B
Zinzino AB Business Overview & Revenue Model
Company Description
Operating as a direct sales enterprise, Zinzino AB (publ) markets and distributes a comprehensive selection of nutritional supplements, coffee products, coffee machines, and associated accessories. The company's diverse offerings encompass health-...
How the Company Makes Money
Zinzino primarily makes money by selling health and wellness products and related test kits directly to consumers through a multi-level/direct-selling model. Revenue is generated mainly from (1) product sales of nutritional supplements (e.g., omeg...
Zinzino AB Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
86
Very Positive
Cash Flow
90
Very Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.49B | 3.17B | 2.21B | 1.76B | 1.36B | 1.29B |
| Gross Profit | 983.35M | 272.48M | 732.48M | 645.93M | 378.45M | 345.39M |
| EBITDA | 457.61M | 305.82M | 253.59M | 245.88M | 117.02M | 137.95M |
| Net Income | 372.83M | 324.32M | 169.17M | 163.74M | 67.70M | 86.20M |
Balance Sheet | ||||||
| Total Assets | 2.30B | 1.75B | 1.21B | 842.13M | 651.25M | 605.21M |
| Cash, Cash Equivalents and Short-Term Investments | 889.20M | 771.00M | 463.05M | 321.24M | 161.88M | 235.73M |
| Total Debt | 67.02M | 41.99M | 46.06M | 61.38M | 49.58M | 38.94M |
| Total Liabilities | 1.14B | 1.05B | 818.94M | 578.34M | 490.88M | 453.49M |
| Stockholders Equity | 1.16B | 707.20M | 386.14M | 259.97M | 154.45M | 143.05M |
Cash Flow | ||||||
| Free Cash Flow | 636.63M | 529.96M | 295.19M | 234.36M | 17.92M | 143.82M |
| Operating Cash Flow | 646.35M | 541.87M | 309.11M | 246.14M | 42.86M | 153.49M |
| Investing Cash Flow | -67.40M | -91.91M | -98.67M | -11.92M | -35.42M | -11.98M |
| Financing Cash Flow | -130.23M | -113.12M | -68.63M | -74.87M | -81.28M | -49.00M |
Zinzino AB Technical Analysis
Positive
129.20
Price Trends
132.18
Negative
133.68
Negative
135.92
Negative
Market Momentum
-0.17
Negative
51.70
Neutral
49.83
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:ZZ.B, the sentiment is Positive. The current price of 129.2 is below the 20-day moving average (MA) of 129.56, below the 50-day MA of 132.18, and below the 200-day MA of 135.92, indicating a neutral trend. The MACD of -0.17 indicates Negative momentum. The RSI at 51.70 is Neutral, neither overbought nor oversold. The STOCH value of 49.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:ZZ.B.
Zinzino AB Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | kr5.15B | 12.86 | 51.57% | 4.64% | 42.70% | 86.19% | |
76 Outperform | kr15.95B | 18.48 | 14.72% | 2.48% | 0.10% | 29.53% | |
63 Neutral | kr1.70B | 15.13 | 3.73% | 2.34% | -2.47% | 460.15% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | kr111.51M | 14.17 | ― | 2.02% | 3.50% | 58.41% | |
56 Neutral | kr3.44B | 43.00 | 1.16% | 0.66% | 4.84% | 22.61% | |
43 Neutral | kr2.46B | -4.52 | -11.29% | ― | 3.21% | -722.98% |
* Consumer Defensive Sector Average
SE:ZZ.B
Zinzino AB
137.30
-57.49
-29.51%
SE:CLA.B
Cloetta AB
55.00
23.29
73.45%
SE:MSON.B
Midsona AB Class B
11.55
3.57
44.77%
SE:SECARE
Swedencare AB
21.85
-15.66
-41.74%
SE:HUMBLE
Humble Group AB
5.37
-2.23
-29.34%
SE:NNH
New Nordic Healthbrands AB
18.25
-4.38
-19.36%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.